(Q34771993)

4 August 2017

0 references

1 reference

title

Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis (English)

1 reference

4 August 2017

0 references

1 reference

J Evans

1

0 references

publication date

18 April 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

22

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

751-760

1 reference

Antioxidants and age-related eye disease. Current and future perspectives

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Risk factors for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

A randomized trial of aspirin and beta-carotene among U.S. physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Vitamin E supplementation and macular degeneration: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

High dose zinc increases hospital admissions due to genitourinary complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

7 January 2021

Visaline in the treatment of age-related macular degeneration: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

7 January 2021

Oral zinc in macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.100

7 January 2021

Identifiers

DOI

10.1038/EYE.2008.100

1 reference

Dimensions Publication ID

4 August 2017

1043534572

0 references

1 reference